1Khanna R, Diamond DJ. Human cytomegalovirus vaccine:time to look for alternative options[J]. Trends Mol Med, 2006,12(1):26-33.
2Prichard MN, Penfold MF,, Duke GM, et al. A review of genetic differences between limited and extensively passaged human cytomegalovirus strains [J]. Rev Med Virol,2001,11(3): 191-200.
3Murphy E, Yu D, Grimwood J, et al. Coding potential of laboratory and clinical strains of human cytomegalovirus[J]. Proc Natl Acad Sci USA, 2003,100(25): 14976-14981.
4Wang D, Shenk T. Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism [J]. J Virol,2005,79(16): 10330-10338.
5Gerna G, Percivalle E, Lilleri D, et al. Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viralantigen presentation to CD8^+T cells[J]. J Gen Virol, 2005,86(Pt2) : 275-284.
6Hahn G, Revello MG, Patrone M, et al. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes [J]. J Virol , 2004,78(18) : 10023-10033.
7Schleiss MR, Heineman TC. Progress toward an elusive goal:current status of cytomegalovirus vaccines [J]. Expert Rev Vaccines, 2005,4(3) : 381-406.
8Heineman TC, Schleiss M, Bernstein DI,et al. A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines [J]. J Infect Dis, 2006, 193(10):1350-1360.
9Pass RF, Duliege AM, Boppana S, et al. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant[J]. J Infect Dis, 1999,180(4):970-975.
10Frey SE, Harrison C, Pass RF, et al. Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine [J]. J Infect Dis, 1999,180(5): 1700-1703.
4St George K,Boyd M J,Lipson S M,et al.A multisite trial comparing two cytomegalovirus(CMV) pp65 antigenemia test kits,biotest CMV brite and Bartels/Argene CMV antigenemia[J].J Clin Microbiol,2000,38(4):1430-1433.
5Griffiths P D.Baboonian C.Rutter D,et al.Congenital and maternal cytomegalovirus infections in a london population[J].Br J Obtet Gynecol,1991,98(2):135-140.
6De Ia Hoz R E,Stephens G.Sherlock C.Diagnosis and treatment approaches of CMV infections in adult patients[J].J Clin Virol,2002,25(Suppl 2):1-12.
7Tsutsui Y,Kawasaki H,Kosugi I.Reactivation of latent cytomegalovirus infection in mouse brain cells deteced after transfer to brain slice cultures[J].J Virol,2002,76(14):7247-7254.
8Sia I G.Patel R.New strategies for prevention and therapy of cytomegalovirus infection and disease in solid organ transplant recipients[J].Clin Microbiol Rev,2000,13(1):83-121.
9Gaytant MA,Steegers EA,Semmekrot RA,et al.Cogenital cytomegalovirus infection:review of the epidemiology and outcome[J].Obstet Gynecol,2002,57(4):245-256.
10Boeckh Mw,Leisenring SR,Riddell RA,et al.Late cytomegalovirus disease and mortality in allogeneic hematopoietic stem cell transplant recipients:importance of viral load and T cell immunity[J].Blood,2003,101:407-414.
